TrialPanorama/TrialPanorama-database huggingface dataset:
Study NCT04635410 — Safety Biomarker (SAF): Hydroxyphenylpyruvate dioxygenase
Genes: HPD; PPD
Study NCT02746133 — Surrogate Endpoint (SUR): Serum calcium
Study NCT02746133 — Pharmacodynamic Biomarker (PDY): Serum phosphate
Study NCT02746133 — Surrogate Endpoint (SUR): Serum phosphate
Study NCT03007979 — Predictive Biomarker (PRD): Hormone receptor
Study NCT00482703 — Predictive Biomarker (PRD): BCR mRNA
Genes: BCR; BCR1; D22S11
Study NCT00482703 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase ABL1
Genes: ABL1; ABL; JTK7
Study NCT02399410 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT00696891 — Predictive Biomarker (PRD): MPL mRNA
Genes: MPL; TPOR
Study NCT00345969 — Surrogate Endpoint (SUR): Serum testosterone
Study NCT03244904 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study NCT00648739 — Predictive Biomarker (PRD): CD200 mRNA
Genes: CD200; MOX1; MOX2; My033
Study NCT04643080 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT04643080 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT04643080 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT02900105 — Surrogate Endpoint (SUR): Serum testosterone
Study NCT01328106 — Predictive Biomarker (PRD): GNAQ mRNA
Genes: GNAQ; GAQ
Study NCT00759785 — Predictive Biomarker (PRD): IGF1R mRNA
Genes: IGF1R
Study NCT00759785 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study NCT01785511 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04741555 — Surrogate Endpoint (SUR): Serum uric acid
Study NCT02792114 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT03432364 — Predictive Biomarker (PRD): BCL11A mRNA
Genes: BCL11A; CTIP1; EVI9; KIAA1809; ZNF856
Study NCT00783315 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00741572 — Safety Biomarker (SAF): Reactive oxygen species
Study NCT01715675 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study NCT01715675 — Surrogate Endpoint (SUR): Serum LDL cholesterol
Study NCT01715675 — Safety Biomarker (SAF): Th2 cell
Study NCT04646655 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): D-dimer
Study NCT00912327 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study NCT00485979 — Surrogate Endpoint (SUR): Pathological complete response
Study NCT02064946 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT04355767 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT04120701 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study NCT01141569 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT00755664 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Monitoring Biomarker (MOI): Vitamin B12
Study NCT01472887 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT02194439 — Predictive Biomarker (PRD): IL1RL1 mRNA
Genes: IL1RL1; DER4; ST2; T1
Study NCT00311675 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT01068691 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02275780 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT01280903 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05053048 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT04027777 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03315325 — Predictive Biomarker (PRD): KISS1R mRNA
Genes: KISS1R; AXOR12; GPR54
Study NCT00555477 — Predictive Biomarker (PRD): Hormone receptor
Study NCT01251965 — Predictive Biomarker (PRD): JAK1 mRNA
Genes: JAK1; JAK1A; JAK1B
Study NCT01251965 — Predictive Biomarker (PRD): JAK2 mRNA
Genes: JAK2
Study NCT02830724 — Predictive Biomarker (PRD): CD70 mRNA
Genes: CD70; CD27L; CD27LG; TNFSF7
Study NCT04904692 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT03574753 — Predictive Biomarker (PRD): Proto-oncogene c-Met
Genes: MET
Study NCT04234165 — Surrogate Endpoint (SUR): Serum sodium
Study NCT04445753 — Safety Biomarker (SAF): B-type natriuretic peptide
Genes: NPPB
Study NCT00306358 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Monitoring Biomarker (MOI): Vitamin B12
Study NCT00924105 — Safety Biomarker (SAF): Interleukin 1
Study NCT03256955 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04584255 — Predictive Biomarker (PRD): PALB2 mRNA
Genes: PALB2; FANCN
Study NCT00216073 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT04486027 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT04486027 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT02905929 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02098512 — Predictive Biomarker (PRD): Lymphocyte activation antigen CD30
Genes: TNFRSF8; CD30; D1S166E
Study NCT01402102 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT01402102 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01402102 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study NCT02440347 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01876082 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT01876082 — Predictive Biomarker (PRD): PDGFA mRNA
Genes: PDGFA; PDGF1
Study NCT05465057 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05682911 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT05682911 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05682911 — Pharmacodynamic Biomarker (PDY): Superoxide dismutase Cu-Zn
Genes: SOD1
Study NCT05896449 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT02774395 — Predictive Biomarker (PRD): CX3CL1 mRNA
Genes: CX3CL1; FKN; NTT; SCYD1; A-152E5.2
Study NCT02774395 — Predictive Biomarker (PRD): CX3CR1 mRNA
Genes: CX3CR1; CMKBRL1; GPR13
Study NCT01452841 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00130195 — Predictive Biomarker (PRD): BCR mRNA
Genes: BCR; BCR1; D22S11
Study NCT00130195 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase ABL1
Genes: ABL1; ABL; JTK7
Study NCT01979536 — Predictive Biomarker (PRD): Lymphocyte activation antigen CD30
Genes: TNFRSF8; CD30; D1S166E
Study NCT05817487 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04413500 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02398929 — Predictive Biomarker (PRD): ADRB1 mRNA
Genes: ADRB1; ADRB1R; B1AR
Study NCT02398929 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04195646 — Predictive Biomarker (PRD): APC mRNA
Genes: APC; DP2.5
Study NCT04499573 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT04499573 — Predictive Biomarker (PRD): CD22 mRNA
Genes: CD22; SIGLEC2
Study NCT03409848 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT03879135 — Safety Biomarker (SAF): von Willebrand factor
Genes: VWF; F8VWF
Study NCT02009345 — Predictive Biomarker (PRD): FH mRNA
Genes: FH
Study NCT04959097 — Predictive Biomarker (PRD): RB1
Genes: RB; PPP1R130
Study NCT04959097 — Pharmacodynamic Biomarker (PDY): Retinoblastoma-associated protein
Genes: RB1
Study NCT02006472 — Pharmacodynamic Biomarker (PDY): Huntingtin
Genes: HTT; HD; IT15
Study NCT04690686 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT02435108 — Predictive Biomarker (PRD): Proto-oncogene c-Met
Genes: MET
Study NCT02688491 — Predictive Biomarker (PRD): PITX1 mRNA
Genes: PITX1; BFT; PTX1
Study NCT02688491 — Predictive Biomarker (PRD): FOXE3 mRNA
Genes: FOXE3; FKHL12; FREAC8
Study NCT02688491 — Predictive Biomarker (PRD): TWF2 mRNA
Genes: TWF2; PTK9L; MSTP011
Study NCT02688491 — Predictive Biomarker (PRD): EHBP1L1 mRNA
Genes: EHBP1L1
Study NCT02688491 — Predictive Biomarker (PRD): RIN1 mRNA
Genes: RIN1
Study NCT02553265 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01750528 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT03774732 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study NCT03774732 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study NCT00236301 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT01604551 — Pharmacodynamic Biomarker (PDY): Blood coagulation
Study NCT01368133 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Plasma DNA
Study NCT01377025 — Predictive Biomarker (PRD): PDGFRB mRNA
Genes: PDGFRB; PDGFR; PDGFR1
Study NCT01377025 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT00979706 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT02679014 — Pharmacodynamic Biomarker (PDY): Cathepsin S
Genes: CTSS
Study NCT01378377 — Predictive Biomarker (PRD): MAP2K1 mRNA
Genes: MAP2K1; MEK1; PRKMK1
Study NCT01378377 — Pharmacodynamic Biomarker (PDY): Extracellular signal-regulated kinase
Study NCT04419090 — Predictive Biomarker (PRD): FH mRNA
Genes: FH
Study NCT02556502 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Microtubule-associated protein tau
Genes: MAPT; MAPTL; MTBT1; TAU
Study NCT00672386 — Predictive Biomarker (PRD): MTTP mRNA
Genes: MTTP; MTP
Study NCT03026140 — Predictive Biomarker (PRD); Safety Biomarker (SAF): COX2 mRNA
Genes: PTGS2; COX2
Study NCT03587740 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT01254136 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT00136422 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT02538016 — Surrogate Endpoint (SUR): Urinary cystine
Study NCT03486912 — Predictive Biomarker (PRD): FGF21 mRNA
Genes: FGF21; UNQ3115/PRO10196
Study NCT00029107 — Predictive Biomarker (PRD): Leukocyte surface antigen Leu-16
Genes: MS4A1; CD20
Study NCT00557700 — Predictive Biomarker (PRD): TAC1 mRNA
Genes: TAC1; NKA; NKNA; TAC2
Study NCT00641576 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT01491685 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02027662 — Pharmacodynamic Biomarker (PDY): Serum phosphate
Study NCT00288990 — Predictive Biomarker (PRD): IFIT1 mRNA
Genes: IFIT1; G10P1; IFI56; IFNAI1; ISG56
Study NCT00288990 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT04821804 — Predictive Biomarker (PRD); Safety Biomarker (SAF): FGG mRNA
Genes: FGG; PRO2061
Study NCT04821804 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT03875378 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT03685383 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT02276781 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT02276781 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): D-dimer
Study NCT06047210 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-X-C motif chemokine 10
Genes: CXCL10; INP10; SCYB10
Study NCT06047210 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Interferon gamma
Genes: IFNG
Study NCT01111942 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT03675126 — Predictive Biomarker (PRD): DMD mRNA
Genes: DMD
Study NCT03302325 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study NCT04511832 — Predictive Biomarker (PRD): Hormone receptor
Study NCT00912847 — Predictive Biomarker (PRD): AFP mRNA
Genes: AFP; HPAFP
Study NCT01670539 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00424749 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study NCT00446524 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01059227 — Predictive Biomarker (PRD): CRH mRNA
Genes: CRH
Study NCT02709499 — Predictive Biomarker (PRD): LBP mRNA
Genes: LBP
Study NCT02709499 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT00731172 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT00891579 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT00891579 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT03840603 — Monitoring Biomarker (MOI): Procalcitonin
Study NCT01782443 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT02775084 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT00565526 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04353401 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT01231659 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study NCT00113074 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02536625 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT02007512 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT04928170 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT04928170 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT04928170 — Safety Biomarker (SAF): Interleukin 1
Study NCT04928170 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT04928170 — Predictive Biomarker (PRD): IL6
Genes: IL-6; BSF2; HGF; HSF
Study NCT00574288 — Predictive Biomarker (PRD): CD38 mRNA
Genes: CD38
Study NCT04243850 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT04243850 — Predictive Biomarker (PRD): SLC5A2 mRNA
Genes: SLC5A2; SGLT2
Study NCT04158544 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study NCT02297438 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT02297438 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study NCT03922984 — Predictive Biomarker (PRD): ASL mRNA
Genes: ASL
Study NCT01267227 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04824573 — Surrogate Endpoint (SUR): Forced vital capacity
Study NCT00211848 — Predictive Biomarker (PRD): PC mRNA
Genes: PC
Study NCT01287468 — Pharmacodynamic Biomarker (PDY): Stromal cell-derived factor 1
Genes: CXCL12; SDF1; SDF1A; SDF1B
Study NCT01287468 — Predictive Biomarker (PRD): CXCL14 mRNA
Genes: CXCL14; MIP2G; NJAC; SCYB14; PSEC0212; UNQ240/PRO273
Study NCT01287468 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT01287468 — Predictive Biomarker (PRD): Thymidylate synthase 
Genes: TYMS; TS; OK/SW-cl.29
Study NCT01905813 — Predictive Biomarker (PRD): JAK1 mRNA
Genes: JAK1; JAK1A; JAK1B
Study NCT02666768 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Interferon gamma
Genes: IFNG
Study NCT02714335 — Predictive Biomarker (PRD): PRAME mRNA
Genes: PRAME; MAPE; OIP4
Study NCT02714335 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT02714335 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT02781753 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Serum albumin
Genes: ALB; GIG20; GIG42; PRO0903; PRO1708; PRO2044; PRO2619; PRO2675; UNQ696/PRO1341
Study NCT02002949 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02474316 — Monitoring Biomarker (MOI): HBV DNA
Study NCT02905318 — Predictive Biomarker (PRD): CDK4 mRNA
Genes: CDK4
Study NCT03099954 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00754351 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT02231879 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT02231879 — Predictive Biomarker (PRD): CXCR4 mRNA
Genes: CXCR4
Study NCT03953235 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study NCT00123695 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00571844 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02743208 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT04663763 — Predictive Biomarker (PRD): Microsatellite instability
Study NCT02228941 — Predictive Biomarker (PRD): NFIL3 mRNA
Genes: NFIL3; E4BP4; IL3BP1
Study NCT02228941 — Pharmacodynamic Biomarker (PDY): Signal transducer and activator of transcription 3
Genes: STAT3; APRF
Study NCT02228941 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Immunoglobulin E
Study NCT02228941 — Safety Biomarker (SAF): IL4
Genes: BSF1; IL-4; BCGF1; BCGF-1; MGC79402
Study NCT01770470 — Pharmacodynamic Biomarker (PDY): Serum phosphate
Study NCT02723786 — Safety Biomarker (SAF): Interleukin 18
Genes: IL18; IGIF; IL1F4
Study NCT03358199 — Predictive Biomarker (PRD): AMH mRNA
Genes: AMH; MIF
Study NCT01483716 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00163202 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT02349594 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT05215431 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT05215431 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT00136500 — Predictive Biomarker (PRD): ARC mRNA
Genes: ARC; KIAA0278
Study NCT01940471 — Monitoring Biomarker (MOI): HBV DNA
Study NCT03747068 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT03811457 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT05688462 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03682016 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03016936 — Predictive Biomarker (PRD): Proto-oncogene c-Met
Genes: MET
Study NCT02183259 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study NCT02422342 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01548573 — Predictive Biomarker (PRD): GCNT2 mRNA
Genes: GCNT2; GCNT5; II; NACGT1
Study NCT01548573 — Predictive Biomarker (PRD): EFS mRNA
Genes: EFS; CASS3
Study NCT00133068 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00704119 — Predictive Biomarker (PRD): CD80 mRNA
Genes: CD80; CD28LG; CD28LG1; LAB7
Study NCT00704119 — Predictive Biomarker (PRD): CD28 mRNA
Genes: CD28
Study NCT00381667 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01337713 — Predictive Biomarker (PRD): GAD1 mRNA
Genes: GAD1; GAD; GAD67
Study NCT03358108 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study NCT03358108 — Monitoring Biomarker (MOI): HBV DNA
Study NCT03371433 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT00513110 — Predictive Biomarker (PRD): AMPD1 mRNA
Genes: AMPD1
Study NCT00513110 — Predictive Biomarker (PRD): AMPD2 mRNA
Genes: AMPD2
Study NCT00513110 — Predictive Biomarker (PRD): AMPD3 mRNA
Genes: AMPD3
Study NCT00718003 — Surrogate Endpoint (SUR): Forced vital capacity
Study NCT01915238 — Predictive Biomarker (PRD): AMD1 mRNA
Genes: AMD1; AMD
Study NCT01581086 — Predictive Biomarker (PRD): PAH mRNA
Genes: PAH
Study NCT01581086 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01974869 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT03454802 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04069689 — Predictive Biomarker (PRD): EPX mRNA
Genes: EPX; EPER; EPO; EPP
Study NCT04288739 — Predictive Biomarker (PRD): XIST
Study NCT02063074 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT03480568 — Predictive Biomarker (PRD): PCSK9 mRNA
Genes: PCSK9; NARC1; PSEC0052
Study NCT00784290 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT00784290 — Pharmacodynamic Biomarker (PDY): Fibroblast growth factor receptor
Study NCT01212653 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT01556464 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03310450 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT03310450 — Safety Biomarker (SAF): Cardiac troponin I
Genes: TNNI3; TNNC1
Study NCT01892592 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03995732 — Pharmacodynamic Biomarker (PDY): Superoxide dismutase Cu-Zn
Genes: SOD1
Study NCT03496012 — Predictive Biomarker (PRD): CHM mRNA
Genes: CHM; REP1; TCD
Study NCT04264247 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02228304 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT00761787 — Predictive Biomarker (PRD): GCNT2 mRNA
Genes: GCNT2; GCNT5; II; NACGT1
Study NCT00761787 — Predictive Biomarker (PRD): ACR mRNA
Genes: ACR; ACRS
Study NCT04316377 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT04485143 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT01926184 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT03992664 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT00029874 — Pharmacodynamic Biomarker (PDY): Huntingtin
Genes: HTT; HD; IT15
Study NCT05861479 — Predictive Biomarker (PRD): PAH mRNA
Genes: PAH
Study NCT04458662 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Lactate dehydrogenase
Study NCT01414881 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT02925702 — Predictive Biomarker (PRD): AR mRNA
Genes: AR; DHTR; NR3C4
Study NCT02169050 — Predictive Biomarker (PRD): VDR mRNA
Genes: VDR; NR1I1
Study NCT01351480 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT00003861 — Predictive Biomarker (PRD): BCR mRNA
Genes: BCR; BCR1; D22S11